Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-15

Clinical Trial Update: Tolerability, Safety and Efficacy of Flexibly Dosed Paliperidone ER in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating tolerability, safety and efficacy of flexibly dosed Paliperidone ER in schizophrenia. The results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paliperidone ER (paliperidone)

Snippet

Sponsor: Janssen-Cilag, S.A. | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2013-03-15